234 related articles for article (PubMed ID: 34020891)
1. Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials.
Kuo YC; Lai CC; Wang YH; Chen CH; Wang CY
J Microbiol Immunol Infect; 2021 Oct; 54(5):865-875. PubMed ID: 34020891
[TBL] [Abstract][Full Text] [Related]
2. Duration of fever and symptoms in children after treatment with baloxavir marboxil and oseltamivir during the 2018-2019 season and detection of variant influenza a viruses with polymerase acidic subunit substitutions.
Saito R; Osada H; Wagatsuma K; Chon I; Sato I; Kawashima T; Saito T; Kodo N; Ono Y; Shimada Y; Phyu W; Shobugawa Y
Antiviral Res; 2020 Nov; 183():104951. PubMed ID: 32987032
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Antiviral Agents for Seasonal Influenza Outcomes in Healthy Adults and Children: A Systematic Review and Network Meta-analysis.
Liu JW; Lin SH; Wang LC; Chiu HY; Lee JA
JAMA Netw Open; 2021 Aug; 4(8):e2119151. PubMed ID: 34387680
[TBL] [Abstract][Full Text] [Related]
4. Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol.
Ishiguro N; Morioka I; Nakano T; Furukawa M; Tanaka S; Kinoshita M; Manabe A
BMC Infect Dis; 2021 Aug; 21(1):777. PubMed ID: 34372769
[TBL] [Abstract][Full Text] [Related]
5. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
Hayden FG; Sugaya N; Hirotsu N; Lee N; de Jong MD; Hurt AC; Ishida T; Sekino H; Yamada K; Portsmouth S; Kawaguchi K; Shishido T; Arai M; Tsuchiya K; Uehara T; Watanabe A;
N Engl J Med; 2018 Sep; 379(10):913-923. PubMed ID: 30184455
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients - a Bayesian network meta-analysis.
Taieb V; Ikeoka H; Wojciechowski P; Jablonska K; Aballea S; Hill M; Hirotsu N
Curr Med Res Opin; 2021 Feb; 37(2):225-244. PubMed ID: 33079575
[TBL] [Abstract][Full Text] [Related]
7. Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir.
Salvatore M; Laplante JM; Soave R; Orfali N; Plate M; van Besien K; St George K
Transpl Infect Dis; 2020 Aug; 22(4):e13336. PubMed ID: 32449254
[TBL] [Abstract][Full Text] [Related]
8. Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2).
Baker J; Block SL; Matharu B; Burleigh Macutkiewicz L; Wildum S; Dimonaco S; Collinson N; Clinch B; Piedra PA
Pediatr Infect Dis J; 2020 Aug; 39(8):700-705. PubMed ID: 32516282
[TBL] [Abstract][Full Text] [Related]
9. Virological and clinical outcomes in outpatients treated with baloxavir or oseltamivir: A Japanese multicenter study in the 2019-2020 influenza season.
Chong Y; Kawai N; Tani N; Bando T; Takasaki Y; Shindo S; Ikematsu H
Antiviral Res; 2021 Aug; 192():105092. PubMed ID: 34052230
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical efficacy and safety of baloxavir marboxil versus oseltamivir as the treatment for influenza virus infections: A systematic review and meta-analysis.
Shiraishi C; Kato H; Hagihara M; Asai N; Iwamoto T; Mikamo H
J Infect Chemother; 2024 Mar; 30(3):242-249. PubMed ID: 37866622
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of the Frequency of Prescription and Pharmacy Revisits between Baloxavir Marboxil and Neuraminidase Inhibitors in Influenza-Infected Pediatric Patients during the 2019-2020 Influenza Season.
Norikoshi Y; Ikeda T; Sasahara K; Hamada M; Torigoe E; Nagae M; Tashiro T; Horio F; Saruwatari J; Uchida Y; Anraku M
Biol Pharm Bull; 2020; 43(12):1960-1965. PubMed ID: 33268716
[TBL] [Abstract][Full Text] [Related]
12. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
Ison MG; Portsmouth S; Yoshida Y; Shishido T; Mitchener M; Tsuchiya K; Uehara T; Hayden FG
Lancet Infect Dis; 2020 Oct; 20(10):1204-1214. PubMed ID: 32526195
[TBL] [Abstract][Full Text] [Related]
13. [A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients].
Taieb V; Ikeoka H; Ma F; Borkowska K; Aballea S; Tone K; Hirotsu N
Ter Arkh; 2020 Dec; 92(11):122-131. PubMed ID: 33720617
[TBL] [Abstract][Full Text] [Related]
14. Neuraminidase inhibitors and single dose baloxavir are effective and safe in uncomplicated influenza: a meta-analysis of randomized controlled trials.
Tejada S; Tejo AM; Peña-López Y; Forero CG; Corbella X; Rello J
Expert Rev Clin Pharmacol; 2021 Jul; 14(7):901-918. PubMed ID: 33861168
[TBL] [Abstract][Full Text] [Related]
15. Baloxavir treatment of oseltamivir-resistant influenza A/H1pdm09 in two immunocompromised patients.
Macesic N; Laplante JM; Aaron JG; DiMango EA; Miko BA; Pereira MR; Reshef R; St George K
Transpl Infect Dis; 2021 Jun; 23(3):e13542. PubMed ID: 33278052
[TBL] [Abstract][Full Text] [Related]
16. The antiviral effects of baloxavir marboxil against influenza A virus infection in ferrets.
Kitano M; Matsuzaki T; Oka R; Baba K; Noda T; Yoshida Y; Sato K; Kiyota K; Mizutare T; Yoshida R; Sato A; Kamimori H; Shishido T; Naito A
Influenza Other Respir Viruses; 2020 Nov; 14(6):710-719. PubMed ID: 32533654
[TBL] [Abstract][Full Text] [Related]
17. Rapid health technology assessment of the novel endonuclease inhibitor baloxavir for the treatment of influenza.
Huang G; Tian Y; Cui W; Zhang X; Zhao Y; Liu X
J Chemother; 2024 Jul; 36(4):267-282. PubMed ID: 37767970
[TBL] [Abstract][Full Text] [Related]
18. Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.
Li Y; Wang X; Liao Y; Zeng Y; Lin W; Zhuang W
BMC Infect Dis; 2024 May; 24(1):446. PubMed ID: 38724914
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
Komeda T; Takazono T; Hosogaya N; Ogura E; Fujiwara M; Miyauchi H; Ajisawa Y; Iwata S; Watanabe H; Honda K; Kitanishi Y; Hara K; Mukae H
Clin Infect Dis; 2021 Jun; 72(11):e859-e867. PubMed ID: 33103200
[TBL] [Abstract][Full Text] [Related]
20. Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study.
Yokoyama T; Sakaguchi H; Ishibashi T; Shishido T; Piedra PA; Sato C; Tsuchiya K; Uehara T
Pediatr Infect Dis J; 2020 Aug; 39(8):706-712. PubMed ID: 32433222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
